RCT Details

PRO-ACTIVE is an open, multi-site trial currently enrolling across three hospital sites in Canada and six in the United States, with two more sites to be added soon. Collectively, our target enrollment is 952 patients. This trial is expected to close in January 2022.

PRO-ACTIVE is a pragmatic clinical trial, meaning that it explores a “real world” approach in the design and implementation of this randomized clinical trial. The primary outcome of feeding tube dependency was chosen, as it is equally valued by all stakeholders, including patients, caregivers and therapy providers.

For more information, please visit the Patient-Centered Outcomes Research Institute.

For detailed study information on ClinicalTrials.gov please click here.


As of November 2021, 60% of the enrolment target (n=952) has been met.